Harry Bushong

President and cofounder of nanoTox, Inc., Harry Bushong’s expertise includes work in the life sciences, raising capital for startups and leveraging value in intellectual property.

In 2003, Mr. Bushong worked with The Olmsted Group, a New York life sciences merchant bank with a licensed portfolio including Intellectual Property from Columbia University, Wisconsin University, MIT, Vanderbilt and Baylor College of Medicine in the fields of stem cells, genomics, biotech and hepatocytes. Mr. Bushong assisted several companies formed around a proprietary piece of intellectual property, including Omnimmune Corp., Plurion, Zirus (formerly Avatar), and Amphioxus. Amphioxus recently merged with Plurion to form Stem Cell Innovations, Inc. In addition, he worked with both public and private enterprises at Aurora Financial Services, a private NASD broker/dealer focused on the energy sector.

Mr. Bushong formed Wired Capital a private equity network series to assist early stage investors identify promising technological and industrial enterprises in Austin, Houston, Chicago, New York, San Francisco and Miami. He also helped transform a solutions management animation company into one of Austin’s earliest streaming media companies, securing three rounds of investments, a $3.5 Million encoding contract, and an international management team to promote the business model.

Mr. Bushong earned his National Association Of Securities Dealers Series 7 and 63 licenses while with Prudential Financial Services in Austin.